Outlook Therapeutics, Inc. · NASDAQ:OTLK
Great Point Partners LLC reported a 8.18% stake in Outlook Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Great Point Partners LLC reported a 8.18% stake in Outlook Therapeutics, Inc., 2,220,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 8.18%
- Shares
- 2,220,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Great Point Partners, LLC | 8.18% | 2,220,000 |
| Dr. Jeffrey R. Jay, M.D. | 8.18% | 2,220,000 |
| Ms. Lillian Nordahl | 8.18% | 2,220,000 |
Source
Related
- Outlook Therapeutics, Inc.
- Great Point Partners LLC
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G/A · Great Point Partners LLC · Aug 14, 2025
- Schedule 13G/A · Great Point Partners LLC · May 15, 2025
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026